Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | ONCOLOGY//CELL BIOLOGY//BIOCHEMISTRY & MOLECULAR BIOLOGY | 2934640 |
200 | 3 | ONCOLOGY//PACLITAXEL//THYMIDYLATE SYNTHASE | 52806 |
978 | 2 | 5 FLUOROURACIL//DIHYDROPYRIMIDINE DEHYDROGENASE//THYMIDINE PHOSPHORYLASE | 10904 |
1359 | 2 | EPOTHILONES//PACLITAXEL//COMBRETASTATIN | 8558 |
1389 | 2 | PEMETREXED//NON SMALL CELL LUNG CANCER//ANTIFOLATE | 8368 |
1497 | 2 | CISPLATIN//ISOLATED LIMB PERFUSION//IFOSFAMIDE | 7807 |
1657 | 2 | FEBRILE NEUTROPENIA//METASTATIC BREAST CANCER//NEUTROPENIA | 7171 |
2101 | 2 | RIBONUCLEOTIDE REDUCTASE//DEOXYCYTIDINE KINASE//GEMCITABINE | 5516 |
3129 | 2 | CHEMOTHERAPY INDUCED PERIPHERAL NEUROPATHY//VINCRISTINE//VINFLUNINE | 2439 |
3271 | 2 | HAND FOOT SYNDROME//HYPERSENSITIVITY REACTION//RADIATION RECALL | 2043 |
Terms with highest relevance score |
rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|---|
1 | ONCOLOGY | WoSSC | 405542 | 46% | 3% | 24128 |
2 | PACLITAXEL | authKW | 318424 | 3% | 29% | 1848 |
3 | THYMIDYLATE SYNTHASE | authKW | 300880 | 1% | 73% | 698 |
4 | OXALIPLATIN | authKW | 267307 | 2% | 44% | 1023 |
5 | 5 FLUOROURACIL | authKW | 264830 | 3% | 32% | 1419 |
6 | CISPLATIN | authKW | 261439 | 4% | 21% | 2168 |
7 | CAPECITABINE | authKW | 258221 | 2% | 53% | 826 |
8 | DOCETAXEL | authKW | 248774 | 2% | 34% | 1245 |
9 | CANCER CHEMOTHERAPY AND PHARMACOLOGY | journal | 246878 | 3% | 24% | 1769 |
10 | GEMCITABINE | authKW | 225353 | 2% | 31% | 1248 |
Web of Science journal categories |
chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | Oncology | 405542 | 46% | 3% | 24128 |
2 | Pharmacology & Pharmacy | 40469 | 18% | 1% | 9566 |
3 | Chemistry, Medicinal | 13217 | 5% | 1% | 2859 |
4 | Biochemistry & Molecular Biology | 3258 | 11% | 0% | 5955 |
5 | Hematology | 2844 | 3% | 1% | 1616 |
6 | Toxicology | 1273 | 2% | 0% | 1207 |
7 | Chemistry, Organic | 1089 | 4% | 0% | 2010 |
8 | Dermatology | 1065 | 2% | 0% | 852 |
9 | Respiratory System | 889 | 2% | 0% | 905 |
10 | Infectious Diseases | 795 | 2% | 0% | 1044 |
Address terms |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | MED ONCOL | 127970 | 6% | 7% | 3326 |
2 | ONCOL | 34417 | 4% | 3% | 2189 |
3 | MED ONCOL UNIT | 19669 | 0% | 13% | 264 |
4 | MED ONCOL SERV | 17899 | 0% | 12% | 260 |
5 | SCREENING TECHNOL BRANCH | 17576 | 0% | 35% | 85 |
6 | HEMATOL ONCOL | 17556 | 2% | 3% | 1196 |
7 | CANC TREATMENT DIAGFREDERICK CANC | 14523 | 0% | 68% | 36 |
8 | CLIN ONCOL | 13439 | 1% | 6% | 421 |
9 | CANC TREATMENT DIAGNIH | 12317 | 0% | 41% | 51 |
10 | SLOTERVAART HOSP | 12217 | 0% | 34% | 61 |
Journals |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | CANCER CHEMOTHERAPY AND PHARMACOLOGY | 246878 | 3% | 24% | 1769 |
2 | SEMINARS IN ONCOLOGY | 96710 | 2% | 18% | 926 |
3 | ANNALS OF ONCOLOGY | 62346 | 2% | 11% | 952 |
4 | ANTI-CANCER DRUGS | 58026 | 1% | 17% | 575 |
5 | JOURNAL OF CLINICAL ONCOLOGY | 52151 | 2% | 7% | 1221 |
6 | CANCER TREATMENT REPORTS | 46570 | 1% | 19% | 418 |
7 | INVESTIGATIONAL NEW DRUGS | 31673 | 1% | 14% | 375 |
8 | EUROPEAN JOURNAL OF CANCER | 31241 | 1% | 7% | 745 |
9 | ANTICANCER RESEARCH | 30761 | 2% | 5% | 1029 |
10 | AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS | 30353 | 1% | 11% | 462 |
Author Key Words |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass | LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | PACLITAXEL | 318424 | 3% | 29% | 1848 | Search PACLITAXEL | Search PACLITAXEL |
2 | THYMIDYLATE SYNTHASE | 300880 | 1% | 73% | 698 | Search THYMIDYLATE+SYNTHASE | Search THYMIDYLATE+SYNTHASE |
3 | OXALIPLATIN | 267307 | 2% | 44% | 1023 | Search OXALIPLATIN | Search OXALIPLATIN |
4 | 5 FLUOROURACIL | 264830 | 3% | 32% | 1419 | Search 5+FLUOROURACIL | Search 5+FLUOROURACIL |
5 | CISPLATIN | 261439 | 4% | 21% | 2168 | Search CISPLATIN | Search CISPLATIN |
6 | CAPECITABINE | 258221 | 2% | 53% | 826 | Search CAPECITABINE | Search CAPECITABINE |
7 | DOCETAXEL | 248774 | 2% | 34% | 1245 | Search DOCETAXEL | Search DOCETAXEL |
8 | GEMCITABINE | 225353 | 2% | 31% | 1248 | Search GEMCITABINE | Search GEMCITABINE |
9 | FEBRILE NEUTROPENIA | 203862 | 1% | 65% | 528 | Search FEBRILE+NEUTROPENIA | Search FEBRILE+NEUTROPENIA |
10 | THYMIDINE PHOSPHORYLASE | 174594 | 1% | 76% | 389 | Search THYMIDINE+PHOSPHORYLASE | Search THYMIDINE+PHOSPHORYLASE |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 3 |